OpenURL Connection Search

Select item for more details and to access through your institution.

NK/T-cell lymphoma nasal type with an unusual clinical course.
Published in:
2014
By:
- Radochová, Vladimíra;
- Radocha, Jakub;
- Nová, Markéta;
- Belada, David;
- Slezák, Radovan
Publication type:
Letter to the Editor
Five years of experience with rituximab plus high-dose dexamethasone for relapsed/refractory chronic lymphocytic leukemia.
Published in:
2016
By:
- imkovič, Martin;
- Motyčková, Monika;
- Belada, David;
- Vodárek, Pavel;
- Kapoor, Rahul;
- Jaffar, Hamna;
- Vrbacký, Filip;
- ák, Pavel;
- Smolej, Luká;
- Šimkovič, Martin;
- Žák, Pavel;
- Smolej, Lukáš
Publication type:
journal article
Primární testikulární lymfomy.
Published in:
Internal Medicine / Vnitrni Lekarstvi, 2017, v. 63, n. 6, p. 415
By:
- Motyčková, Monika;
- Vosáhlová, Vladimíra;
- Belada, David;
- Šimkovič, Martin;
- Žák, Pavel
Publication type:
Article
PERIPHERAL T-CELL LYMPHOMA, UNSPECIFIED - THE ANALYSIS OF THE DATA FROM THE CZECH LYMPHOMA STUDY GROUP (CLSG) REGISTRY.
Published in:
Biomedical Papers of the Medical Faculty of Palacky University in Olomouc, 2007, v. 151, n. 1, p. 103, doi. 10.5507/bp.2007.019
By:
- Prochazka, Vit;
- Trneny, Marek;
- Pytlik, Robert;
- Vasova, Ingrid;
- Kral, Zdenek;
- Belada, David;
- Kozak, Tomas;
- Kubackova, Katerina;
- Siffnerova, Hana;
- Matuska, Milan;
- Lysy, Milan;
- Bolomska, Inge;
- Petrakova, Katarina;
- Otavova, Barbora;
- Pribylova, Jana;
- Svecova, Jirina;
- Papajik, Tomas;
- Hamouzova, Michaela;
- Petrova, Marketa;
- Zapletalova, Jana
Publication type:
Article
Low‐dose fludarabine and cyclophosphamide combined with rituximab in the first‐line treatment of elderly/comorbid patients with chronic lymphocytic leukaemia/small lymphocytic lymphoma (CLL/SLL): long‐term results of project Q‐lite by the Czech CLL Study Group
Published in:
British Journal of Haematology, 2021, v. 193, n. 4, p. 769, doi. 10.1111/bjh.17373
By:
- Smolej, Lukáš;
- Brychtová, Yvona;
- Cmunt, Eduard;
- Doubek, Michael;
- Špaček, Martin;
- Belada, David;
- Šimkovič, Martin;
- Stejskal, Lukáš;
- Zygulová, Irena;
- Urbanová, Renata;
- Brejcha, Martin;
- Zuchnická, Jana;
- Móciková, Heidi;
- Kozák, Tomáš
Publication type:
Article
Pixantrone plus rituximab versus gemcitabine plus rituximab in patients with relapsed aggressive B‐cell non‐Hodgkin lymphoma not eligible for stem cell transplantation: a phase 3, randomized, multicentre trial (PIX306).
Published in:
British Journal of Haematology, 2020, v. 188, n. 2, p. 240, doi. 10.1111/bjh.16255
By:
- Pettengell, Ruth;
- Długosz‐Danecka, Monika;
- Andorsky, David;
- Belada, David;
- Georgiev, Pencho;
- Quick, Donald;
- Singer, Jack W.;
- Singh, Simran B.;
- Pallis, Athanasios;
- Egorov, Anton;
- Salles, Gilles
Publication type:
Article
Prospective subgroup analyses of the randomized MCL‐002 (SPRINT) study: lenalidomide <italic>versus</italic> investigator's choice in relapsed or refractory mantle cell lymphoma.
Published in:
British Journal of Haematology, 2018, v. 180, n. 2, p. 224, doi. 10.1111/bjh.15025
By:
- Arcaini, Luca;
- Lamy, Thierry;
- Walewski, Jan;
- Belada, David;
- Mayer, Jiri;
- Radford, John;
- Jurczak, Wojciech;
- Morschhauser, Franck;
- Alexeeva, Julia;
- Rule, Simon;
- Cabeçadas, José;
- Campo, Elias;
- Pileri, Stefano A.;
- Biyukov, Tsvetan;
- Patturajan, Meera;
- Casadebaig Bravo, Marie‐Laure;
- Trnĕný, Marek;
- the SPRINT Trial Investigators
Publication type:
Article
The use of formalin-fixed, paraffin-embedded lymph node samples for the detection of minimal residual disease in mantle cell lymphoma.
Published in:
British Journal of Haematology, 2015, v. 169, n. 1, p. 145, doi. 10.1111/bjh.13182
By:
- Kalinova, Marketa;
- Fronkova, Eva;
- Klener, Pavel;
- Forsterova, Kristina;
- Lokvenc, Milan;
- Mejstrikova, Ester;
- Belada, David;
- Mocikova, Heidi;
- Trneny, Marek;
- Kodet, Roman;
- Trka, Jan
Publication type:
Article
PERIAORTÁLNÍ LYMFOM IMITUJÍCÍ INFEKČNÍ KOMPLIKACI PO EVAR.
Published in:
Czech Radiology / Ceska Radiologie, 2018, v. 72, n. 2, p. 96
By:
- Vajda, Milan;
- Raupach, Jan;
- Krajina, Antonín;
- Lojík, Miroslav;
- Hoffmann, Petr;
- Hůlek, Michal;
- Živný, Ondřej;
- Malý, Radovan;
- Vršanská, Veronika;
- Belada, David
Publication type:
Article
A New Prognostic Score for Elderly Patients with Diffuse Large B-Cell Lymphoma Treated with R-CHOP: The Prognostic Role of Blood Monocyte and Lymphocyte Counts Is Absent.
Published in:
PLoS ONE, 2014, v. 9, n. 7, p. 1, doi. 10.1371/journal.pone.0102594
By:
- Procházka, Vít;
- Pytlík, Robert;
- Janíková, Andrea;
- Belada, David;
- Šálek, David;
- Papajík, Tomáš;
- Campr, Vít;
- Fürst, Tomáš;
- Furstova, Jana;
- Trněný, Marek
Publication type:
Article
Experiences in the treatment of refractory chylothorax associated with lymphoproliferative disorders.
Published in:
2019
By:
- Pospiskova, Jana;
- Smolej, Lukas;
- Belada, David;
- Simkovic, Martin;
- Motyckova, Monika;
- Sykorova, Alice;
- Stepankova, Pavla;
- Zak, Pavel
Publication type:
journal article
Effectiveness of tixagevimab/cilgavimab in patients with hematological malignancies as a pre-exposure prophylaxis to prevent severe COVID-19: a Czech retrospective multicenter study.
Published in:
Annals of Hematology, 2024, v. 103, n. 3, p. 981, doi. 10.1007/s00277-023-05572-0
By:
- Demel, Ivo;
- Skopal, David;
- Šafránková, Eliška;
- Rozsívalová, Petra;
- Jindra, Pavel;
- Šrámek, Jiří;
- Turková, Adéla;
- Vydra, Jan;
- Labská, Klára;
- Vedrová, Jana;
- Čerňan, Martin;
- Szotkowski, Tomáš;
- Móciková, Heidi;
- Hynková, Lenka;
- Šušol, Ondrej;
- Kováčová, Ingrid;
- Belada, David;
- Hájek, Roman
Publication type:
Article
Ibrutinib in mantle cell lymphoma: a real-world retrospective multi-center analysis of 77 patients treated in the Czech Republic.
Published in:
Annals of Hematology, 2023, v. 102, n. 1, p. 107, doi. 10.1007/s00277-022-05023-2
By:
- Obr, Ales;
- Benesova, Katerina;
- Janikova, Andrea;
- Mocikova, Heidi;
- Belada, David;
- Hruskova, Andrea;
- Vockova, Petra;
- Salek, David;
- Sykorova, Alice;
- Furst, Tomas;
- Malarikova, Diana;
- Papajik, Tomas;
- Trneny, Marek;
- Klener, Pavel
Publication type:
Article
The interval between progression and therapy initiation is the key prognostic parameter in relapsing diffuse large B cell lymphoma: analysis from the Czech Lymphoma Study Group database (NIHIL).
Published in:
2020
By:
- Janikova, Andrea;
- Michalka, Jozef;
- Bortlicek, Zbynek;
- Chloupkova, Renata;
- Campr, Vit;
- Kopalova, Natasa;
- Klener, Pavel;
- Benesova, Katerina;
- Hamouzova, Jitka;
- Belada, David;
- Prochazka, Vit;
- Pytlik, Robert;
- Pirnos, Jan;
- Duras, Juraj;
- Mocikova, Heidi;
- Trneny, Marek
Publication type:
journal article
First-line therapy for T cell lymphomas: a retrospective population-based analysis of 906 T cell lymphoma patients.
Published in:
2019
By:
- Janikova, Andrea;
- Chloupkova, Renata;
- Campr, Vit;
- Klener, Pavel;
- Hamouzova, Jitka;
- Belada, David;
- Prochazka, Vit;
- Pytlik, Robert;
- Pirnos, Jan;
- Duras, Juraj;
- Mocikova, Heidi;
- Bortlicek, Zbynek;
- Kopalova, Natasa;
- Mayer, Jiri;
- Trneny, Marek
Publication type:
journal article
The incidence of biopsy-proven transformation in follicular lymphoma in the rituximab era. A retrospective analysis from the Czech Lymphoma Study Group (CLSG) database.
Published in:
Annals of Hematology, 2018, v. 97, n. 4, p. 669, doi. 10.1007/s00277-017-3218-0
By:
- Janikova, Andrea;
- Bortlicek, Zbynek;
- Campr, Vit;
- Kopalova, Natasa;
- Benesova, Katerina;
- Hamouzova, Michaela;
- Belada, David;
- Prochazka, Vit;
- Pytlik, Robert;
- Vokurka, Samuel;
- Pirnos, Jan;
- Duras, Juraj;
- Mocikova, Heidi;
- Mayer, Jiri;
- Trneny, Marek
Publication type:
Article
Cutaneous natural killer (NK) / T-cell lymphoma: nasal type with extensive facial destruction.
Published in:
International Journal of Dermatology, 2009, v. 48, n. 12, p. 1338, doi. 10.1111/j.1365-4632.2009.04197.x
By:
- Košt´ál, Milan;
- Košt´álová, Marie;
- Belada, David;
- Laco, Jan
Publication type:
Article
Polatuzumab vedotin plus bendamustine and rituximab in patients with relapsed/refractory diffuse large B‐cell lymphoma in the real world.
Published in:
European Journal of Haematology, 2022, v. 109, n. 2, p. 162, doi. 10.1111/ejh.13784
By:
- Vodicka, Prokop;
- Benesova, Katerina;
- Janikova, Andrea;
- Prochazka, Vit;
- Belada, David;
- Mocikova, Heidi;
- Steinerova, Katerina;
- Duras, Juraj;
- Karban, Josef;
- Hanackova, Veronika;
- Sykorova, Alice;
- Obr, Ales;
- Trneny, Marek
Publication type:
Article
Emergence of a lymphoma imitating an infectious infiltration surrounding the infrarenal aorta after EVAR.
Published in:
VASA. Zeitschrift für Gefässkrankheiten, 2019, v. 48, n. 6, p. 531, doi. 10.1024/0301-1526/a000806
By:
- Vajda, Milan;
- Raupach, Jan;
- Krajina, Antonín;
- Hoffmann, Petr;
- Hůlek, Michal;
- Živný, Ondřej;
- Malý, Radovan;
- Vršanská, Veronika;
- Belada, David
Publication type:
Article
Several factors that predict the outcome of large B‐cell lymphoma patients who relapse/progress after chimeric antigen receptor (CAR) T‐cell therapy can be identified before cell administration.
Published in:
Cancer Medicine, 2024, v. 13, n. 17, p. 1, doi. 10.1002/cam4.70138
By:
- Sýkorová, Alice;
- Folber, František;
- Polgárová, Kamila;
- Móciková, Heidi;
- Ďuraš, Juraj;
- Steinerová, Kateřina;
- Obr, Aleš;
- Heindorfer, Adriana;
- Ladická, Miriam;
- Lukáčová, Ľubica;
- Čellárová, Erika;
- Plameňová, Ivana;
- Belada, David;
- Janíková, Andrea;
- Trněný, Marek;
- Jančárková, Tereza;
- Procházka, Vít;
- Vranovský, Andrej;
- Králiková, Margaréta;
- Vydra, Jan
Publication type:
Article
Complex evaluation of serum immunoglobulin levels in patients with chronic lymphocytic leukemia: Significant increase in IgA after first‐line chemoimmunotherapy.
Published in:
Cancer Medicine, 2024, v. 13, n. 15, p. 1, doi. 10.1002/cam4.7399
By:
- Vodárek, Pavel;
- Écsiová, Dominika;
- Řezáčová, Vladimíra;
- Souček, Ondřej;
- Šimkovič, Martin;
- Vokurková, Doris;
- Belada, David;
- Žák, Pavel;
- Smolej, Lukáš
Publication type:
Article
A comprehensive assessment of lymphocyte subsets, their prognostic significance, and changes after first‐line therapy administration in patients with chronic lymphocytic leukemia.
Published in:
Cancer Medicine, 2023, v. 12, n. 6, p. 6956, doi. 10.1002/cam4.5492
By:
- Vodárek, Pavel;
- Écsiová, Dominika;
- Řezáčová, Vladimíra;
- Souček, Ondřej;
- Šimkovič, Martin;
- Vokurková, Doris;
- Belada, David;
- Žák, Pavel;
- Smolej, Lukáš
Publication type:
Article
TCL-150: The ECHELON-2 Trial: 5-Year Results of a Randomized, Double-Blind, Phase 3 Study of Brentuximab Vedotin and CHP (A+CHP) Versus CHOP in Frontline Treatment of Patients with CD30-Positive Peripheral T-Cell Lymphoma.
Published in:
Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S411, doi. 10.1016/S2152-2650(21)01925-X
By:
- Iyer, Swaminathan;
- Trümper, Lorenz;
- O'Connor, Owen A.;
- Pro, Barbara;
- Illidge, Tim;
- Advani, Ranjana;
- Bartlett, Nancy L.;
- Christensen, Jacob Haaber;
- Morschhauser, Franck;
- Domingo-Domenech, Eva;
- Rossi, Giuseppe;
- Won Seog Kim;
- Feldman, Tatyana;
- Menne, Tobias;
- Belada, David;
- Illès, Árpád;
- Tobinai, Kensei;
- Kunihiro Tsukasaki;
- Su-Peng Yeh;
- Shustov, Andrei
Publication type:
Article
Poster: TCL-150: The ECHELON-2 Trial: 5-Year Results of a Randomized, Double-Blind, Phase 3 Study of Brentuximab Vedotin and CHP (A+CHP) Versus CHOP in Frontline Treatment of Patients with CD30-Positive Peripheral T-Cell Lymphoma.
Published in:
Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S247, doi. 10.1016/S2152-2650(21)01557-3
By:
- Iyer, Swaminathan;
- Trümper, Lorenz;
- O'Connor, Owen A.;
- Pro, Barbara;
- Illidge, Tim;
- Advani, Ranjana;
- Bartlett, Nancy L.;
- Christensen, Jacob Haaber;
- Morschhauser, Franck;
- Domingo-Domenech, Eva;
- Rossi, Giuseppe;
- Kim, Won Seog;
- Feldman, Tatyana;
- Menne, Tobias;
- Belada, David;
- Illès, Árpád;
- Tobinai, Kensei;
- Tsukasaki, Kunihiro;
- Yeh, Su-Peng;
- Shustov, Andrei
Publication type:
Article
Oral Abstract: TCL-150: The ECHELON-2 Trial: 5-Year Results of a Randomized, Double-Blind, Phase 3 Study of Brentuximab Vedotin and CHP (A+CHP) Versus CHOP in Frontline Treatment of Patients with CD30-Positive Peripheral T-Cell Lymphoma.
Published in:
Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S203, doi. 10.1016/S2152-2650(21)01276-3
By:
- Iyer, Swaminathan;
- Trümper, Lorenz;
- O'Connor, Owen A.;
- Pro, Barbara;
- Illidge, Tim;
- Advani, Ranjana;
- Bartlett, Nancy L.;
- Christensen, Jacob Haaber;
- Morschhauser, Franck;
- Domingo-Domenech, Eva;
- Rossi, Giuseppe;
- Won Seog Kim;
- Feldman, Tatyana;
- Menne, Tobias;
- Belada, David;
- Illès, Árpád;
- Tobinai, Kensei;
- Tsukasaki, Kunihiro;
- Su-Peng Yeh;
- Shustov, Andrei
Publication type:
Article
Burkitt lymphoma-a retrospective analysis of data from the Registry of the Czech Lymphoma Study Group with external validation of the Burkitt lymphoma International Prognostic Index.
Published in:
Neoplasma, 2022, v. 69, n. 6, p. 1466, doi. 10.4149/neo_2022_221030N1064
By:
- SÝKOROVÁ, Alice;
- PROCHÁZKA, Vít;
- MÓCIKOVÁ, Heidi;
- JANÍKOVÁ, Andrea;
- PYTLÍK, Robert;
- BELADA, David;
- BENEŠOVÁ, Kateřina;
- KLENER Jr., Pavel;
- ĎURAŠ, Juraj;
- SMOLEJ, Lukáš;
- CAMPR, Vít;
- BLAHOVCOVÁ, Petra;
- TRNĚNÝ, Marek
Publication type:
Article
Primary results from the double-blind, placebo-controlled, phase 3 SHINE study of ibrutinib in combination with bendamustine-rituximab (BR) and R maintenance as a first-line treatment for older patients with mantle cell lymphoma (MCL).
Published in:
Acta Haematologica Polonica, 2022, v. 53, n. A, p. 42
By:
- Jurczak, Wojciech;
- Gouill, Steven Le;
- Jerkeman, Mats;
- Trotman, Judith;
- Zinzani, Pier Luigi;
- Belada, David;
- Boccomini, Carola;
- Flinn, Ian W.;
- Giri, Pratyush;
- Goy, Andre;
- Hamlin, Paul A.;
- Hermine, Olivier;
- Hernández-Rivas, José-ángel;
- Xiaonan Hong;
- Seok Jin Kim;
- Lewis, David;
- Yuko Mishima;
- Özcan, Muhit;
- Perini, Guilherme Fleury;
- Pocock, Christopher
Publication type:
Article
Rituximab, Cyclophosphamide and Dexamethasone (RCD) Chemoimmunotherapy for Relapsed Chronic Lymphocytic Leukaemia.
Published in:
European Journal of Clinical Investigation, 2021, v. 51, n. 4, p. 1, doi. 10.1111/eci.13421
By:
- Šimkovič, Martin;
- Vodárek, Pavel;
- Motyčková, Monika;
- Écsiová, Dominika;
- Rozsívalová, Petra;
- Móciková, Heidi;
- Štěpánková, Pavla;
- Sýkorová, Alice;
- Hrochová, Kateřina;
- Vrbacký, Filip;
- Belada, David;
- Žák, Pavel;
- Smolej, Lukáš
Publication type:
Article
Potential loss of prognostic significance of minimal residual disease assessment after R-CHOP-based induction in elderly patients with mantle cell lymphoma in the era of rituximab maintenance.
Published in:
2018
By:
- Klener, Pavel;
- Fronkova, Eva;
- Kalinova, Marketa;
- Belada, David;
- Forsterova, Kristina;
- Pytlik, Robert;
- Blahovcova, Petra;
- Simkovic, Martin;
- Salek, David;
- Mocikova, Heidi;
- Prochazka, Vit;
- Janikova, Andrea;
- Vaskova, Martina;
- Mejstrikova, Ester;
- Kodet, Roman;
- Trka, Jan;
- Trneny, Marek
Publication type:
journal article
Alternating R-CHOP and R-cytarabine is a safe and effective regimen for transplant-ineligible patients with a newly diagnosed mantle cell lymphoma.
Published in:
2018
By:
- Klener, Pavel;
- Fronkova, Eva;
- Belada, David;
- Forsterova, Kristina;
- Pytlik, Robert;
- Kalinova, Marketa;
- Simkovic, Martin;
- Salek, David;
- Mocikova, Heidi;
- Prochazka, Vit;
- Blahovcova, Petra;
- Janikova, Andrea;
- Markova, Jana;
- Obr, Ales;
- Berkova, Adela;
- Kubinyi, Jozef;
- Vaskova, Martina;
- Mejstrikova, Ester;
- Campr, Vit;
- Jaksa, Radek
Publication type:
journal article
Statin use is safe and does not impact prognosis in patient with de novo follicular lymphoma treated with immunochemotherapy: An exploratory analysis of the PRIMA cohort study.
Published in:
American Journal of Hematology, 2016, v. 91, p. 410, doi. 10.1002/ajh.24305
By:
- Bachy, Emmanuel;
- Estell, Jane A.;
- Van de Neste, Eric;
- Bouabdallah, Réda;
- Bargay, Joan;
- Delmer, Alain;
- Gelas-Dore, Bénédicte;
- Gomes da Silva, Maria;
- Fitoussi, Olivier;
- Belada, David;
- Maisonneuve, Hervé;
- Intragumtornchai, Tanin;
- Lamy, Thierry;
- Dartigues, Peggy;
- Francis Seymour, John;
- Salles, Gilles
Publication type:
Article
Statin use is safe and does not impact prognosis in patient with de novo follicular lymphoma treated with immunochemotherapy: An exploratory analysis of the PRIMA cohort study.
Published in:
American Journal of Hematology, 2016, v. 91, n. 4, p. 410, doi. 10.1002/ajh.24305
By:
- Bachy, Emmanuel;
- Estell, Jane A.;
- Van de Neste, Eric;
- Bouabdallah, Réda;
- Bargay, Joan;
- Delmer, Alain;
- Gelas-Dore, Bénédicte;
- da Silva, Maria Gomes;
- Fitoussi, Olivier;
- Belada, David;
- Maisonneuve, Hervé;
- Intragumtornchai, Tanin;
- Lamy, Thierry;
- Dartigues, Peggy;
- Seymour, John Francis;
- Salles, Gilles
Publication type:
Article
Peripheral T-Cell Lymphomas Involving the Central Nervous System: A Report From the Czech Lymphoma Study Group Registry.
Published in:
Frontiers in Oncology, 2022, v. 12, p. 1, doi. 10.3389/fonc.2022.874462
By:
- Mocikova, Heidi;
- Pytlík, Robert;
- Benesova, Katerina;
- Janikova, Andrea;
- Duras, Juraj;
- Sykorova, Alice;
- Steinerova, Katerina;
- Prochazka, Vit;
- Campr, Vit;
- Belada, David;
- Trneny, Marek
Publication type:
Article
Lymfomatoidní granulomatóza -- minulost a současnost.
Published in:
Internal Medicine / Vnitrni Lekarstvi, 2014, v. 60, n. 3, p. 225
By:
- Sýkorová, Alice;
- Campr, Vít;
- Kašparová, Petra;
- Kočová, Eva;
- Belada, David;
- Trněný, Marek;
- Žák, Pavel
Publication type:
Article
Rituximab maintenance significantly reduces early follicular lymphoma progressions in patients treated with frontline R-CHOP.
Published in:
EJHaem, 2020, v. 1, n. 1, p. 1, doi. 10.1002/jha2.60
By:
- Procházka, Vít;
- Belada, David;
- Janíková, Andrea;
- Benešová, Kateřina;
- Mociková, Heidi;
- Ďuraš, Juraj;
- Pirnos, Jan;
- Kopečková, Kateřina;
- Campr, Vít;
- Fürst, Tomáš;
- Pytlík, Robert;
- Sýkorová, Alice;
- Michalka, Jozef;
- Dlouhá, Jitka;
- Papajík, Tomáš;
- Trněný, Marek
Publication type:
Article

Found: 35